Skip to content

Jakarta Acute Coronary Syndrome Registry

Jakarta Acute Coronary Syndrome Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02319473
Acronym
JAC Registry
Enrollment
28812
Registered
2014-12-18
Start date
2007-01-31
Completion date
2022-12-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Keywords

system of care, acute myocardial infarction, registry, Primary PCI, Fibrinolytic therapy

Brief summary

Jakarta acute coronary syndrome enrolled patients with acute coronary syndrome admitted to the emergency department of all health centers in Jakarta and the surrounding area.

Detailed description

The JAC registry is an ongoing prospective, multi center, observational study that aims to enroll ACS patients who admitted to the emergency department (ED) of all health centers in Jakarta and the surrounding area. The registry has been collecting data since 2007, and used extensively since 2014. Currently, the JAC registry is the main source of data for measuring the performance of the STEMI network in the region, namely Jakarta Cardiovascular Care Unit Network System. The STEMI network in Jakarta has been introduced as an integral part of the government project since 2010/2011. STEMI was diagnosed based on the typical chest pain and ST segment elevation on two or more contiguos leads. The number of primary PCI, fibrinolytic therapy and non-reperfused patients were recorded.

Interventions

OTHERJAC Registry

patients who received acute reperfusion therapy

Sponsors

National Cardiovascular Center Harapan Kita Hospital Indonesia
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* STEMI patients that was diagnosed based on the presence of typical chest pain and ST-segment elevation in two or more contigious leads on the initial ECG

Exclusion criteria

* STEMI patients that was under 18 years

Design outcomes

Primary

MeasureTime frame
The number of primary PCI15 years
In-hospital mortality15 years

Secondary

MeasureTime frame
The number of fibrinolytic therapy15 years
The number of non-reperfused patients15 years

Countries

Indonesia

Contacts

Primary ContactSurya Dharma, MD, PhD
drsuryadharma@yahoo.com+62215684085
Backup ContactAde Priyanto
adepriyanto2003@yahoo.com+62215684085

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026